Curis Inc. (CRIS) is a biopharmaceutical company. The provided filing excerpt is limited to a subsidiary listing (Exhibit 21), identifying Curis Securities Corporation, a Massachusetts-organized subsidiary, as the sole listed entity doing business under its own name. Insufficient detail is available in this excerpt to fully describe Curis Inc.'s products, pipeline, or business operations beyond this subsidiary disclosure.
Q2 FY2026 — expected 2026-08-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-24 | 2025-12-31 | 0001108205-26-000043 | EDGAR | 95K words |
| 2025-03-31 | 2024-12-31 | 0001108205-25-000031 | EDGAR | — |
| 2024-02-08 | 2023-12-31 | 0001108205-24-000010 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001108205-23-000023 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001108205-22-000002 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001108205-21-000003 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001108205-20-000003 | EDGAR | — |
| 2019-03-26 | 2018-12-31 | 0001108205-19-000004 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001108205-18-000005 | EDGAR | — |
| 2017-03-09 | 2016-12-31 | 0001108205-17-000006 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001108205-25-000107 | EDGAR | 23K words |
| 2025-08-05 | 2025-06-30 | 0001108205-25-000080 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001108205-25-000046 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001108205-24-000072 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001108205-24-000062 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001108205-24-000033 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0001108205-23-000074 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001108205-23-000060 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001108205-23-000049 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001108205-22-000023 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001108205-22-000009 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001108205-22-000005 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-19 | 0001108205-26-000030 | EDGAR | 3K words |
| 2026-03-17 | 0001108205-26-000016 | EDGAR | — |
| 2026-02-09 | 0001108205-26-000006 | EDGAR | — |
| 2026-01-08 | 0001108205-26-000002 | EDGAR | — |
| 2025-11-06 | 0001108205-25-000105 | EDGAR | — |
| 2025-10-24 | 0001108205-25-000098 | EDGAR | — |
| 2025-08-22 | 0001108205-25-000093 | EDGAR | — |
| 2025-08-08 | 0001108205-25-000087 | EDGAR | — |
| 2025-08-05 | 0001108205-25-000079 | EDGAR | — |
| 2025-07-02 | 0001108205-25-000072 | EDGAR | — |
377 total filings indexed. 345 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001108205 |
| Ticker | CRIS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report